The idea of using living cells as sensor elements in microfluidic systems is attractive for obtaining multiparametric information from biological systems. Besides the general benefits of miniaturization, the superior control and unique flow properties in microfluidic systems enable the extraction of high-quality data from cell-based biosensors.
Microfluidics
The term microfluidics refers to devices, systems, and methods for the manipulation of fluid flows with characteristic length scales in the micrometer range 7 . Microfluidic systems display fundamentally different properties from everyday perceptions of how fluids behave. The ratio between the moment of inertia and the viscous forces in a fluid system is described by the Reynolds number Re = ρνl / η , where ρ, ν, l, and η are the fluid density, fluid velocity, characteristic length scale, and dynamic viscosity, respectively. Microfluidic systems are typically low Reynolds number systems, and the fluid flow is governed mainly by viscous forces and pressure gradients, with a low moment of inertia. The result is a truly laminar, turbulence-free flow and, since low Reynolds number flows are time independent, flow patterns are reversible 8 . The short length scales involved in microfluidic systems result in other properties, such as high surface-to-volume ratios, small diffusion distances, and small heat capacities. The surface tension of the fluid and the wetting properties of the system can also be significant forces 9 .
The behavior and relative influence of these phenomena will differ greatly depending on the size of the system studied and, in microfluidic systems, the result can be highly counterintuitive. Specifically, the difference in physical behavior between microscopic and macroscopic systems allows for the construction of functionalities that are difficult or even impossible to access on the macroscopic scale. Taking all this into account, one arrives at the conclusion that, rather than trying to design a microfluidic system that is just a downsized copy of a macroscopic system, one should use design rules obtained from the physics of fluid mechanics and diffusion in confined spaces. Examples of microfluidic systems designed in this manner include on-chip gradient generation devices, where solutions are diluted in an automated and highly reproducible manner [10] [11] [12] . Such systems have been applied in chemotaxis and electrophysiology studies 12, 13 . The T-sensor [14] [15] [16] , where particles and/or molecules with different diffusion coefficients can be separated for analytical or preparative purposes, is an example of a sensor that takes advantage of the predictable diffusion behavior of molecules and particles in laminar flows.
Fabrication of microfluidic devices
Developments in microfluidics can be attributed to the adoption of microfabrication technologies from the microelectronics industry, enabling the creation of complex miniaturized systems in materials such as Si, glass, and metals. As a consequence, microfluidic devices were initially composed of Si or glass. These materials possess several advantages, such as excellent chemical and physical stability, solvent compatibility, and optical properties, along with generally very desirable surface properties. The main disadvantage of traditional fabrication techniques resides in the high total cost of the device, dependent on the cost of both the material itself and the method of fabrication.
Traditional micromachining techniques are not widely used today in the fabrication of microfluidic devices for either high-volume production or research purposes, with some exceptions. The microfluidics community has instead driven the development of alternative fabrication technologies and materials, including powderblasting of glass 17, 18 ; injection molding 19, 20 , hot embossing 19, 21 , and laser ablation 22 of polymeric materials such as polycarbonate and polymethylmethacrylate;
and casting techniques such as rapid prototyping in silicone elastomers or epoxies [23] [24] [25] . Apart from powderblasting and laser ablation, these methods all rely on the replication of a master structure that is the negative of the desired structure (Fig. 1) . The master structure is reusable, enabling replication of microfluidic devices with a relatively low cost. The techniques allow the fabrication of microfluidic devices in a large selection of thermoplastic and elastomeric materials that have a wide range of chemical, mechanical, and optical properties. Furthermore, the surface of the materials can be modified -the majority of the thermoplastic materials permanently -by physical as well as chemical methods, giving access to an almost unlimited variety of surface properties. This is important in many cases, both for minimizing adsorption of chemical species such as hydrophobic molecules and proteins to surfaces 20, 26 (a common problem in microfluidic devices because of their intrinsically high surface-to-volume ratios), as well as tailoring surface chemistries for cell growth and control 27, 28 .
Cell-based assays and microfluidics
The term 'cell-based assay' was introduced in the early 1980s and has grown to encompass many different areas in assessing the effects of concentration using fluorescence 29 . Furthermore, different types of cellbased absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) assays are carried out to determine whether the acquired leads have the necessary pharmacokinetic properties and to assess their toxicity. These include permeability studies 30 , assessment of metabolic stability and clearance, and screening for QT interval prolongation using fluorescence-based assays or in vitro electrophysiology 31, 32 .
The driving force for the development of cell-based assays is a desire to develop tests that provide data representative of higher-level biological responses, i.e. results should ideally be comparable to those obtained from animal models or clinical trials. Often, cell-based assays can collect new types of information impossible to obtain by other means. Importantly, implementation of microfluidics technologies into cell-based assays can provide significant advantages in throughput, costs, and data quality. However, conventional assays have been vastly optimized and miniaturized, e.g. 3456 well plates are routinely used 33 .
Although several examples of cell-based assays in microfluidic systems have been demonstrated [34] [35] [36] [37] , there are only a few applications where they have proved to offer advantages over conventional assays: highthroughput screening, ion channel research, and chemotaxis studies.
High-throughput screening
Pharmaceutical companies worldwide own extensive and growing libraries of different compounds, mainly because of the ease in which large numbers of compounds can be synthesized by combinatorial chemistry 38 . If compounds are to be screened with higher throughput at lower costs, miniaturization is an obvious route, resulting in lower volume consumption of chemicals, solvents, and cells 39 .
Caliper Life Sciences has developed a microfluidic system that can be employed in various types of high-throughput screening applications 40 .
The Caliper platform carries out assays that traditionally used conventional, plate-based screening platforms. The key component is a glass microchip with integrated 'sipper' capillaries that 'sips' fluids, e.g. compounds, dyes, buffers, or negative controls from plate wells, while at the same time continuously drawing solutions, e.g. enzyme, substrate, or cell suspensions from integrated, on-chip wells (Fig. 2) . The conditions, and several dose-response scans can be obtained from the same cell. In addition, the well-defined force that originates from the flow and acts on the cell-pipette system stabilizes the patch-clamped cell, allowing extended recording times from one cell, in some cases up to hours 47 . The throughput is 10-100 times greater than conventional
Fig. 3 The patch clamp technique. After a cell has been approached by the pipette (A), a high-resistance seal is achieved on application of negative pressure, resulting in the cell-attached configuration (B). Further application of negative pressure ruptures the membrane, resulting in the whole-cell configuration, i.e. electrical contact with the inside of the cell (C). Inside-out and outside-out configurations are achieved by pulling the pipette away from the cell (D and E). (F) An equivalent electrical circuit of a cell in whole-cell configuration during acquisition of data. These physical parameters set the boundary conditions for temporal resolution and the errors obtained during the recording. E m denotes the membrane potential, R s the series resistance, C p the pipette capacitance, C m the membrane capacitance, and R m the membrane resistance.
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Emerging technologies
Apart from the assays mentioned above, there are few examples of cell-based assays in a microfluidic format that exhibit unique advantages over conventional approaches. However, there are a number of specialized assays and technologies that are very interesting and could become key components in tomorrow's microfluidic cellbased assays.
Chiu and coworkers 67 have demonstrated a microfluidic model for the obstruction of capillary blood vessels by single red blood cells infected with the Plasmodium falciparum parasite, as occurs in severe malaria. Capillary blood vessels were modeled using microfluidic channels fabricated in poly(dimethylsiloxane), and the transport of infected and uninfected red blood cells through the channels was studied. An artificial synapse chip that simulates synaptic transmitter release has also been developed 68 . These models of biological processes would be impossible without the aid of microfluidics. A multilayer soft lithography technique has been developed by Quake and coworkers 69 for fabricating pumps and valves in elastomeric materials. It has been used to make cell sorters 70 and could prove useful in the construction of powerful cell-based assays in microfluidic formats.
Takayama and coworkers 71 have avoided the relatively complex and expensive multistep microfabrication process of multilayer soft lithography in making cell-cultivation devices that operate using elastomeric channels and Braille displays. Their system has been used for long-term cultivation of endothelial cells and observation of their behavior in response to shear stress.
Future outlook
The field of microfluidics is still in its infancy and, until recently, has been highly technology driven. The focus has been on the development of functional components, e.g. pumps and valves, as well as new, costeffective fabrication technologies. As the focus now shifts to applications, completely new types of cell-based assays will result in information that was previously impossible to acquire, as shown in the examples of high-throughput screening, patch clamp, and chemotaxis studies. Although there are many good proposals for the use of microfluidics in cell-based assays, the field has not yet matured to present commercial functional devices apart from those mentioned above. To conclude, the potential of microfluidics will undoubtedly see the technology assume a larger and more important role in the development of cell-based assays for the creation of more and higher quality targets and leads in drug discovery. Microfluidics will also generate discoveries unattainable using conventional, macroscopic approaches.
